Hemodynamic Instability
Conditions
Keywords
fluid and volume management, acid-base balance, goal-directed therapy, transoesophageal doppler
Brief summary
The purpose of this study is to determine whether the administration of a compound of balanced infusion solutions including 50% crystalloid and 50% colloid has a positive impact on acid-base balance in elective hip replacement surgery. The application of the study medication will be carried out through a goal-directed intraoperative therapy by transoesophageal doppler.
Interventions
DRUGInfusion Therapy
Based on changes of stroke volume measured by transoesophageal doppler patients during elective hip surgery will achieve either a unbalanced infusion solution, maximum dose of 100 ml/kg BW, or a compound of balanced infusion solution including 50% crystalloid and 50% colloid, each: maximum dose of 50 ml/kg BW. The study medication will be administered only during surgery.
Sponsors
Charite University, Berlin, Germany
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients at the age of 60 and above who want to undergo an elective hip replacement surgery in the center of musculoskeletal surgery * Offered patient information and written informed consent
Exclusion criteria
* Participation in another trial according to the German Drug Law 30 days to and during the study * Lacking willingness to save and hand out data within the study * Accommodation in an institution due to an official or judicial order * (Unclear) history of alcohol or substances disabuse * Absent knowledge of german language * Analphabetism * Allergy to hydroxyethyl starch or other ingredients of the intravenous solutions * For women: Pregnancy or positive pregnancy test within the preoperative screening * Operation due to case of emergency, polytrauma or pathologic fracture * Only use of regional anaesthesia * American Society of Anaesthesiologists (ASA) classification greater than III * Peripheral or central edema * AIDS (according to the CDC-classification of HIV-infection: category C) * Rheumatoid disease under treatment with Anti-TNF-alpha-Ab and/or high-dose-corticoid-treatment * Immunosuppression therapy * History of bleeding tendency (e.g. von-Willebrand-disease, thrombocytopenia) * Derailed metabolic disorder (e.g. Diabetes mellitus (Glucose \> 300 mg/dl) during the preoperative screening) * Known history of electrolyte disturbance (e.g. Hyperkalemia \> 5.8 mmol/l, Hypernatraemia \> 155 mmol/l) * Known history of acid-base-dysbalances * History of intracranial hemorrhage within one year of participation in the study * Neurological or psychiatric disease with limited contractual capability * Advanced disease of the oesophagus or upper respiratory tract * Operation in the area of the oesophagus or nasopharynx within the last two months * CHF (congestive heart failure) according to (New York Heart Association) classification - NYHA class IV * Liver disease (CHILD B or C cirrhosis, end-stage liver disease (MELD-score greater than 10)) * Conditions after acute or chronic pancreatitis * Renal insufficiency (serum creatinine greater than 2.0 mg/dl or greater than 150 µmol/l or dependency of haemodialysis)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Standard Base Excess | up to 2 days | After administration of 2 litres of study medication. In recovery room. On general ward. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hemodynamic Stability | up to 6 days | Doses and duration of therapy with catecholamins, number and duration of hypotensive episodes |
| Fluid Loss of Drainage | up to 6 days | The quantity of fluids per day losing by drainage during the first three days after surgery |
| Discharge Criteria, Length of Hospital Stay | 5 days up to hospital discharge | Time until fullfilling the hospital discharge criteria (measured by the postanesthesia discharge scoring system (PADSS)), and length of hospital stay |
| Organ Function/Dysfunction | up to 6 days | (Cumulative) frequency of postoperative organ dysfunctions (cerebral, cardiac, pulmonary, renal, gastrointestinal) |
| SID (strong ion difference) | up to 2 days | Change of the SID (strong ion difference) according to the stewart-approach of evalutation acid-base-dysbalances |
| Pain | up to 6 days | Pain of the patient measured by NAS (Numeric analogue scale), VAS (Visual analogue scale), NRS (Numeric rating scale) and BPS (Behavioral pain scale) |
| Incidence of Delirium | up to 6 days | Incidence of delirium measured accordingly by DSM IV (Diagnostic and statistical manual of mental disorders criteria for delirium), Nu-DESC (Nursing delirium screening scale), DDS (Delirium detection score), CAM (Confusion assessment method), CAM-ICU (Confusion assessment method for the ICU), DRS (Delirium rating scale) and ICDSC (Intensive care delirium screening checklist). |
| Incidence of Postoperative Cognitive Deficit (POCD) | up to 90 days after surgery | Measurement of cognitive function by 5 tests out of CANTAB (Cambridge neuropsychological test automated battery) modeled by the ISPOCD1 study (International study of post-operative cognitive dysfunction), Stroop colour word test(SCWT) and verbal learning test(VLT) |
| Mobilisation | up to 6 days | Duration and type of mobilisation |
| Incidence of Infections | up to 5 days | Perioperative Incidence of infections (according to the Centers of Disease and Prevention (CDC)) |
Countries
Germany
Outcome results
None listed